EarningsQ4 2025 Earnings Report

Pro Medicus Limited (PMC) Q4 2025 Earnings Report

4 Followers

Previous Report: Q2 2025

Next Report: Q2 2026

DE:PMC Q4 2025 EPS Results

Actual EPS€0.38

Consensus EPS€0.36

Beat/MissBeat by +€0.02

One Year Ago EPS€0.28

DE:PMC Q4 2025 Revenue Results

Actual Revenue€72.38M

Expected Revenue€72.38M

Beat/MissBeat by +€5.00K

YoY Revenue Growth+32.50%

Earnings Announcement Details

QuarterQ4 2025

Date08/13/2025

TimeAfter Close

Conference CallWednesday, August 13, 2025

DE:PMC Upcoming Earnings

Pro Medicus Limited's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

DE:PMC Q4 2025 Earnings Call

0:00 / 0:00

Q4 2025 Earnings Slide Deck

Q4 2025 Earnings Call Summary

Q4 2025

Earnings Call Date:Aug 13, 2025|

% Change Since:

Earnings Call Sentiment|Positive

The earnings call highlighted strong financial performance with record revenue and profit growth, significant contract wins, and advancements in cloud and AI technology. However, challenges remain in expanding market penetration outside North America and navigating a competitive landscape.

Company Guidance

During the Pro Medicus Limited Full Year Results Briefing, CEO Dr. Sam Hupert highlighted significant achievements for FY '25, with key financial metrics showing substantial improvement. Revenue increased by nearly 32%, profit after tax rose by approximately 40%, and underlying EBIT also saw a 40% rise. Margins improved from mid-72% to 74%, leading to a 36% increase in retained earnings. The company announced a fully franked dividend of $0.30 per share for the half, a 37.5% increase. Pro Medicus secured seven contracts worth $520 million, renewed two large contracts totaling $130 million, and achieved $39 million in upgrades. The company's forward revenue increased from the low $600 million range to $948 million over a five-year period. Additionally, Pro Medicus made strides in cloud deployment, research collaborations, and expanded its product offerings, setting a strong foundation for future growth.

Significant Revenue and Profit Growth

Revenue increased by just under 32%, profit after tax rose approximately 40%, and underlying EBIT was up around 40%. Margins increased from mid-72s to 74%.

Record Year for Sales and Contracts

Won 7 contracts totaling $520 million, renewed 2 large contracts worth $130 million, and secured upgrades for additional products with existing clients for a total of $39 million.

Expansion in North America

North America remains the largest market, contributing to 90% of revenue. Significant contracts included a $330 million contract with Trinity and $57 million with BayCare.

Advancements in Cloud and AI

Pro Medicus is the only company with a 100% full cloud solution at scale, with the ability to work across AWS, Azure, and Google GCP. New AI initiatives include a breast cancer detection algorithm developed with NYU.

Strategic Partnerships and Collaborations

Research collaboration agreement signed with UCSF, adding to partnerships with Mayo and NYU.

DE:PMC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Feb 16, 2027	2027 (Q2)	0.53 / -	1.023	―
Aug 17, 2026	2026 (Q4)	0.44 / 0.46	0.379	22.11% (+0.08)
Feb 11, 2026	2026 (Q2)	0.41 / 1.02	0.309	231.17% (+0.71)
Aug 13, 2025	2025 (Q4)	0.36 / 0.38	0.281	34.67% (+0.10)
Feb 12, 2025	2025 (Q2)	0.31 / 0.31	0.216	42.77% (+0.09)
Aug 13, 2024	2024 (Q4)	0.26 / 0.28	0.207	35.95% (+0.07)
Feb 14, 2024	2024 (Q2)	0.22 / 0.22	0.163	33.08% (+0.05)
Aug 14, 2023	2023 (Q4)	0.21 / 0.21	0.138	49.77% (+0.07)
Feb 14, 2023	2023 (Q2)	0.16 / 0.16	0.123	31.98% (+0.04)
Aug 17, 2022	2022 (Q4)	0.20 / 0.14	0.103	33.94% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed